351 related articles for article (PubMed ID: 23152628)
1. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.
Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G
J Neurosci; 2012 Nov; 32(46):16458-65. PubMed ID: 23152628
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
[TBL] [Abstract][Full Text] [Related]
3. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV
J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
5. Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.
Mohamed LA; Zhu H; Mousa YM; Wang E; Qiu WQ; Kaddoumi A
J Alzheimers Dis; 2017; 56(3):1087-1099. PubMed ID: 28059785
[TBL] [Abstract][Full Text] [Related]
6. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
Xiong M; Wang C; Gratuze M; Saadi F; Bao X; Bosch ME; Lee C; Jiang H; Serrano JR; Gonzales ER; Kipnis M; Holtzman DM
Mol Neurodegener; 2023 Mar; 18(1):17. PubMed ID: 36922879
[TBL] [Abstract][Full Text] [Related]
7. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells.
Lee J; Lee H; Lee H; Shin M; Shin MG; Seo J; Lee EJ; Park SA; Park S
Nat Commun; 2023 Dec; 14(1):8463. PubMed ID: 38123547
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.
Zlokovic BV; Deane R; Sagare AP; Bell RD; Winkler EA
J Neurochem; 2010 Dec; 115(5):1077-89. PubMed ID: 20854368
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice.
Lefterov I; Fitz NF; Cronican AA; Fogg A; Lefterov P; Kodali R; Wetzel R; Koldamova R
J Biol Chem; 2010 Nov; 285(47):36945-57. PubMed ID: 20739292
[TBL] [Abstract][Full Text] [Related]
10. Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.
Kitazawa M; Hsu HW; Medeiros R
Toxicol Sci; 2016 Jul; 152(1):194-204. PubMed ID: 27122238
[TBL] [Abstract][Full Text] [Related]
11. High affinity of β-amyloid proteins to cerebral capillaries: implications in chronic lead exposure-induced neurotoxicity in rats.
Liu LL; Shen X; Gu H; Zhao G; Du Y; Zheng W
Fluids Barriers CNS; 2023 May; 20(1):32. PubMed ID: 37122007
[TBL] [Abstract][Full Text] [Related]
12. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy.
Urmoneit B; Prikulis I; Wihl G; D'Urso D; Frank R; Heeren J; Beisiegel U; Prior R
Lab Invest; 1997 Aug; 77(2):157-66. PubMed ID: 9274858
[TBL] [Abstract][Full Text] [Related]
13. Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes.
Vargas-Soria M; Ramos-Rodriguez JJ; Del Marco A; Hierro-Bujalance C; Carranza-Naval MJ; Calvo-Rodriguez M; van Veluw SJ; Stitt AW; Simó R; Bacskai BJ; Infante-Garcia C; Garcia-Alloza M
Fluids Barriers CNS; 2022 Nov; 19(1):88. PubMed ID: 36345028
[TBL] [Abstract][Full Text] [Related]
14. Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction.
Gireud-Goss M; Mack AF; McCullough LD; Urayama A
Neuroscientist; 2021 Dec; 27(6):668-684. PubMed ID: 33238806
[TBL] [Abstract][Full Text] [Related]
15. Vascular Heparan Sulfate and Amyloid-β in Alzheimer's Disease Patients.
McMillan IO; Gearing M; Wang L
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612775
[TBL] [Abstract][Full Text] [Related]
16. LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Regulates Smooth Muscle Contractility by Modulating Ca
Au DT; Ying Z; Hernández-Ochoa EO; Fondrie WE; Hampton B; Migliorini M; Galisteo R; Schneider MF; Daugherty A; Rateri DL; Strickland DK; Muratoglu SC
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2651-2664. PubMed ID: 30354243
[TBL] [Abstract][Full Text] [Related]
17. STAT3 inhibitor mitigates cerebral amyloid angiopathy and parenchymal amyloid plaques while improving cognitive functions and brain networks.
Mehla J; Singh I; Diwan D; Nelson JW; Lawrence M; Lee E; Bauer AQ; Holtzman DM; Zipfel GJ
Acta Neuropathol Commun; 2021 Dec; 9(1):193. PubMed ID: 34911575
[TBL] [Abstract][Full Text] [Related]
18. Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease.
Pedrós I; Petrov D; Artiach G; Abad S; Ramon-Duaso C; Sureda F; Pallàs M; Beas-Zarate C; Folch J; Camins A
J Nutr Health Aging; 2015 Apr; 19(4):403-12. PubMed ID: 25809804
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.
Sagare AP; Deane R; Zlokovic BV
Pharmacol Ther; 2012 Oct; 136(1):94-105. PubMed ID: 22820095
[TBL] [Abstract][Full Text] [Related]
20. α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation.
Inoue Y; Tasaki M; Masuda T; Misumi Y; Nomura T; Ando Y; Ueda M
Cell Mol Life Sci; 2022 Aug; 79(8):462. PubMed ID: 35916996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
